When selecting a sperm donor, it is a priority for most parents that the donor is genetic disease-free. For Manhattan Cryobank, their promise of thorough screening for each donor has been exposed as faulty. Before November 2014, the Manhattan sperm bank’s genetic disease screening was not up to date. Instead of re-screening the pre-2014 samples, Manhattan Cryobank continued to sell the sperm until July 2018 with no caveat to the public.
Now, Manhattan Cryobank is facing multiple lawsuits regarding their lack of genetic screening. According to the article published on Above the Law:
In addition to punitive and compensatory damages and disgorgement of profits related to the faulty sperm, the plaintiffs request that the court order the bank: 1) to warn class members that the pre-November 1, 2014 sperm was not screened with NGS technology and may contain genetic defects or diseases; and 2) cease and desist from offering sperm for sale without warning that it had not been screened with the latest technology.
Read more on Above the Law.
Photo retrieved from Above the Law.
